Isoptin (Verapamil Hydrochloride)

Verapamil blocks L‑type calcium channels in heart and vascular smooth‑muscle cells, reducing calcium influx. This leads to decreased myocardial contractility, slowed AV‑node conduction, and peripheral vasodilation, which together lower blood pressure and help control abnormal heart rhythms.

The appropriate dose of Isoptin is individualized by the prescribing clinician based on the patient’s specific condition, response to therapy, and any relevant organ‑function considerations. No fixed regimen is provided here.

Safety data for verapamil during pregnancy and lactation are limited. Use is generally reserved for situations where the potential benefit justifies any potential risk to the fetus or infant, and decisions should be made in consultation with a healthcare professional.

To request Isoptin, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Isoptin (verapamil) belongs to the calcium‑channel blocker class, offering rate‑control benefits similar to diltiazem but with a stronger effect on vascular tone. Compared with beta‑blockers, it may be preferred when bronchospasm risk is a concern, though each class has distinct efficacy and safety profiles that guide selection.

Isoptin should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Keep the product away from excess moisture, direct sunlight, and heat sources to maintain its stability.

Isoptin is taken orally as a tablet. It can be swallowed with or without food, but patients should follow the prescribing clinician’s instructions regarding timing and any dietary considerations.

The most concerning adverse events include marked bradycardia, heart block, and severe hypotension. Patients should seek immediate medical attention if they experience fainting, unusually slow heart rate, or a sudden drop in blood pressure.

Isoptin is contraindicated in patients with known severe sinus‑node dysfunction, second‑ or third‑degree AV block without a pacemaker, uncontrolled heart failure, or a history of hypersensitivity to verapamil or other calcium‑channel blockers.